Deepull
Founded 2019 · 71 employees on LinkedIn · 2 known investors
Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries CApr 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Deepull do?
- Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.
- Who are Deepull's investors?
- Deepull's investors include Asabys Partners, Columbus Venture Partners.